Visfatin and SREBP-1c mRNA Expressions and Serum Levels Among Egyptian Women with Polycystic Ovary Syndrome.

Obesity and insulin resistance are common features accompanying polycystic ovary syndrome (PCOS). To analyze the impact of obesity on the expression of the and sterol regulatory element-binding protein ()-1c genes among a group of Egyptian women with PCOS, and to assess their suitability as PCOS biomarkers. Seventy healthy women (control group) (35 nonobese and 35 obese) and 140 women with PCOS (70 nonobese and 70 obese) were enrolled in this study. The and genes' expression analyses were performed via real-time polymerase chain reaction. Serum visfatin and SREBP-1c protein levels were measured with ELISA kits. Among PCOS patients, upregulation of and expression was observed. We did not identify significant differences between the obese and nonobese PCOS patients nor between obese and non-obese controls. The mRNA expression levels of both genes were significantly positively correlated with their serum protein levels, as well as with fasting serum insulin levels, homeostatic model assessments of insulin resistance (HOMA-IR), luteinizing hormone (LH) ratios, LH/follicular stimulating hormone ratios, total testosterone, and free androgens. We observed significant negative correlations between and expression levels and sex hormone binding globulin levels in all studied groups. Receiver operating characteristic curve analyses revealed that combining the and expression data increased the sensitivity (95.92%) and specificity (93.2%) for PCOS diagnoses. Upregulation of and was observed among PCOS patients. These genes may play a role in the pathogenesis of PCOS independent of obesity. Combined and analyses could be used as a noninvasive biomarker for PCOS.